Cargando…
Research into the biological differences and targets in lung cancer patients with diverse immunotherapy responses
BACKGROUND: Immunotherapy has gradually become an important therapy option for lung cancer patients. METHODS: The Cancer Genome Atlas (TCGA) and Gene Expression Omnibus (GEO) databases were responsible for all the public data. RESULTS: In our study, we firstly identified 22 characteristic genes of N...
Autores principales: | Zhang, Xunlang, Wu, Xinhui, Huang, Huang, Du, Kangming, Nie, Yingying, Su, Peiyuan, Li, Yuefei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523410/ https://www.ncbi.nlm.nih.gov/pubmed/36189290 http://dx.doi.org/10.3389/fimmu.2022.1014333 |
Ejemplares similares
-
Machine learning identifies characteristics molecules of cancer associated fibroblasts significantly correlated with the prognosis, immunotherapy response and immune microenvironment in lung adenocarcinoma
por: Wang, Qian, et al.
Publicado: (2022) -
Exploration of the underlying biological differences and targets in ovarian cancer patients with diverse immunotherapy response
por: Chen, Jinjin, et al.
Publicado: (2022) -
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
por: Zhang, Yingzi, et al.
Publicado: (2022) -
Revisiting targeted therapy and immunotherapy for advanced cholangiocarcinoma
por: Du, Jiajia, et al.
Publicado: (2023) -
Integrative analysis illustrates the role of PCDH7 in lung cancer development, cisplatin resistance, and immunotherapy resistance: an underlying target
por: Li, Huakang, et al.
Publicado: (2023)